(E) A few recent articles that summarize the present state of knowledge about the Delta variant from the revue Nature: Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization How […]
(T) An excellent article from Maxime Nauwynck on “how has AI contributed to dealing with the COVID-19 pandemic?” published in Stanford Gradient’s blog. The article looks at the contribution in […]
(E) Sanofi, the largest vaccine manufacturer in the world, and its partner GSK just announced the result of their vaccine that is based on an adjuvanted recombinant protein for their […]
(E) There are countries such as New Zealand and Taiwan, where political and health care officials do not tolerate any spread of the SARS-Cov-2 (note that the political leaders in […]
(E) Another remarkable blog article, “the CureVac Vaccine, and a brief tour through some of the wonders of nature“, from (software engineer) blogger Bert Hubert who also wrote last year […]
(E) A remarkable blog article, “exploring the Supply Chain of the Pfizer/BioNTech and Moderna COVID-19 vaccines“, from another (software engineer) blogger Jonas Neubert on discovering and understanding the supply chain […]
(E) I feel very privileged to not only have received my second Covid-19 vaccine dose today but also that my two doses were an mRNA vaccine, the one from Pfizer-BioNtech. […]
(E) A very interesting article on Professor Ron Davis, from the Stanford Genome Technology Center, trying to save his son from the long-term effects of myalgic encephalomyelitis — a disease […]
(T) A biotech company Adaptive Biotechnologies has developed a new test, called T-Detect Covid, that looks at signals of past Covid infections in the body T cells immune system. The […]
(E) We have now known for over a year the two companies that delivered the first two Covid-19 vaccines – BioNtech and Moderna, based on mRNA. What we are now […]
(T) In this third blog post about the applications of deep learning techniques to structural biology research, I will summarize a recent research study on virus mutation.The recent Covid-19 pandemic […]
(E) Moderna released today new data about the protection of its vaccine against the new SARS-Cov-2 variants: “Moderna COVID-19 Vaccine Variants Update“. Long story short, the Moderna vaccine provides the […]
(E) Today, Moderna announced the results of its phase 3 study, and gave some additional details about its vaccine. Moderna vaccine is slightly more efficient than the one from BioNTech, […]
(E) The second wave is here. Infections have been rising to the roof: Europe, the U.S., South America, and Russia. The U.S have now over 150,000 new daily cases, and […]
(E) Today is a good day! Pharmaceutical giant partner Pfizer announced today that the vaccine developed with its partner BioNTech, a bio-tech company located in Mainz in Germany, against the […]
(E) Taiwan and New Zealand have a huge advantage over other countries fighting the propagation of SARS-CoV-2: they are islands. Closing and reopening offices, schools, restaurants, gyms do not work. […]
(E) Looking back at the mistakes that caused human lives, Professor Philippe Parola, directeur de service de soins et d’unité de recherche à L’Institut Hospitalo-Universitaire (IHU) de Marseilles, looked back […]
(E) Excellent research from UCSF, Institut Pasteur, Gladstone Institutes, and Icahn School of Medicine at Mount Sinai to find the right antiviral drugs for Covid-19: “A SARS-CoV-2 protein interaction map […]
(E) Yale School of Medicine has updated its initial treatment algorithm for hospitalized patients with non–severe COVID-19 which uses hydroxychloroquine and tocilizumab: Yale Releases COVID-19 Treatment Algorithm Covid-19 adult treatment […]
(E) The Vaccine Centre at the London School of Hygiene & Tropical has developed a site that tracks all Covid-19 vaccine candidates as they progress through the development pipeline. The […]
(E) I have heard many times Professor William Dally from Stanford University and nVIDIA’s Chief Scientist talking about training deep learning systems on GPUs. During the shelter, Professor Dally led […]
(E) Latest analyses from Professor Didier Raoult and the Institut Hospitalo-Universitaire (IHU) de Marseille, who conducted early successful tests with the hydroxychloroquine and azithromycin as a treatment to Covid-19, on […]
